Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs

The Australian Trial in Acute Hepatitis C

Dados Bibliográficos

ID14909626
AutoresMaryam Alavi (0000-0003-3512-4938, autor correspondente), Tim Spelman (0000-0001-9204-3216, Burnet Institute), Gail Matthews (0000-0002-1048-6396), Gail V Matthews, Paul Haber (0000-0001-8915-8872, The University of Sydney), Paul S Haber, Carolyn A Day (0000-0003-4277-1412, The University of Sydney), Carolyn Day, Ingrid van Beek, Nick Walsh (0000-0003-3268-5799, Monash University), Barbara Yeung, Julie Bruneau (0000-0002-3484-6456, Centre Hospitalier de l’Université de Montréal), Kathy Petoumenos (0000-0001-7534-7154), Katherine Dolan (0000-0002-9848-807X, UNSW Sydney), Kate Dolan, John M Kaldor, John Kaldor (0000-0002-7639-4355), Gregory J Dore (0000-0002-4741-2622), Margaret Hellard (0000-0002-5055-3266, Burnet Institute), J Grebely (0000-0002-1833-2017)
Ano2015
Volume26
Fascículo10
Páginas976-983
Data de publicação2015-10-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoInternational Journal of Drug Policy (JOURNAL)
Identificadores do periódicoISSN: 0955-3959 • E-ISSN: 1873-4758
EditoraElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2015.05.003
PMID26115881
OpenAlexW1801566764
IdiomaEN
Citações recebidas15
Referências citadas41